Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

Lineage Cell Therapeutics, Inc. ( LCTX ) conducted its Second Quarter 2026 Earnings Call on August 6, 2026. The call included updates from CEO Brian Culley, CFO Jill Howe, and Head of Clinical Operations Priyantha Herath. A press release detailing the financial results for the quarter was issued prior to the call. Management's remarks and responses to questions were based on current information and included forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from expectations.